Navigating Canada's copyright landscape presents a complex challenge. To be blunt , dimethyltryptamine (copyright) remains entirely against the law across Canada . There are no authorized sources obtainable for acquisition . However, perhaps , the regulated status of psilocybin, and the increasing acceptance of copyright treatment , have triggered